PRESS RELEASES

CNH Industrial to announce 2020 Third Quarter financial results on November 5, 2020

London, October 21, 2020

CNH Industrial (NYSE: CNHI / MI: CNHI) announced today that its financial results for the Third Quarter of 2020 will be released on Thursday, November 5, 2020.

A live audio webcast of the 2020 Third Quarter results conference call will begin at 3:30 p.m. CET/ 2:30 p.m. GMT / 9:30 a.m. EST on Thursday, November 5, 2020.

Details for accessing the webcast presentation are available at the following address: http://bit.ly/CNH_Industrial_Q3_2020.

For those unable to participate in the live session, a replay will remain archived in the Investors section of the corporate website (www.cnhindustrial.com) for two weeks following the conference call.

CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) is a global leader in the capital goods sector with established industrial experience, a wide range of products and a worldwide presence. Each of the individual brands belonging to the Company is a major international force in its specific industrial sector: Case IH, New Holland Agriculture and Steyr for tractors and agricultural machinery; Case and New Holland Construction for earth moving equipment; Iveco for commercial vehicles; Iveco Bus and Heuliez Bus for buses and coaches; Iveco Astra for quarry and construction vehicles; Magirus for firefighting vehicles; Iveco Defence Vehicles for defence and civil protection; and FPT Industrial for engines and transmissions. More information can be found on the corporate website: www.cnhindustrial.com

Contacts:

Corporate Communications

Email: [email protected]

Investor Relations

Email: [email protected]

Attachment

Latest News

Brunswick Exploration Options Nickel Property in Quebec

MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (“BRW” or the “Company”) is pleased to announce that is has signed option and purchase agreements from a private company and prospectors to acquire a 100% interest in the Lac Édouard Nickel Project (“Lac Édouard” or the “Property”), located 40 km northeast of the town […]

Junshi Biosciences and AstraZeneca Announce Strategic Collaboration to Commercialize Toripalimab in China

— Junshi grants AstraZeneca exclusive promotion rights of toripalimab in mainland China for the urothelial carcinoma indications and for all indications in non-core areas — Junshi will continue to be responsible for the promotion of other indications in core areas –The companies will continue to explore business collaborations in overseas markets including emerging markets SHANGHAI, […]